Successful use of Remcyte®-based continuous hemodiafiltration in a case of refractory CRS and ICANS complicated by tumor lysis syndrome–associated AKI

Key Points

• Effective use of Remcyte® in managing acute kidney injury related to tumor lysis syndrome.
• Management included continuous hemodiafiltration, leading to improved patient status.
• This case highlights the potential of hemodialysis in treating refractory chronic respiratory syndrome.
• Indicates a need for further exploration of Remcyte® in similar acute conditions.